Alpa Laboratories Share Price Today

Alpa Laboratories appoints Diksha Jaswani as company secretary

Alpa Laboratories appoints Ms. Diksha Jaswani as Company Secretary cum Compliance Officer. The appointment takes effect from September 17, 2026, following Board approval. Ms. Jaswani holds Membership No. A80495 with the Institute of Company Secretaries of India. She has no shareholding in the company and no disclosed relationships with directors.

Alpa Laboratories sets Sept 30 record date for 38th AGM

Alpa Laboratories sets September 30, 2026 as the record date for its 38th AGM. The register of members will be closed from September 23 to September 30, 2026. The AGM will be held via video conference on September 30 at 2:00 pm. The disclosure complies with SEBI Listing Regulations and the Companies Act, 2013.

Alpa Laboratories appoints Radhika Biyani as independent director

Radhika Biyani appointed as additional independent director effective September 5, 2026. Appointment fills vacancy left by Jyoti Jain, who ceased tenure on July 21, 2026. Board reconstituted Audit, Nomination, Stakeholders, and Risk Management committees. Biyani holds no shares in Alpa Laboratories and has no other directorships. Shareholder approval required at ensuing general meeting or via postal ballot.

Alpa Laboratories clarifies Board Meeting date is Aug 13, correcting typo

Alpa Laboratories Limited corrected a typographical error in its Board Meeting intimation, confirming the event is on August 13, 2026, not August 14. The clarification was issued to NSE and BSE on August 11, 2026, by Director Shitil Shah to ensure accurate market communication.

Alpa Laboratories Approves Plan to Set Up Overseas Unit Alpa Biopharm in Nigeria

Alpa Laboratories has granted in-principle approval to explore the incorporation of Alpa Biopharm Limited in Nigeria, in association with Blueseal Pharmaceuticals Limited. The Board approved the move under SEBI LODR Regulations, with no investment made as of July 29, 2026. Final terms including shareholding pattern, capital contribution, and governance structure are yet to be determined, pending statutory approvals in both India and Nigeria.

Alpa Laboratories Q4 Results: Corrects XBRL filing error for Q4FY26

Alpa Laboratories Limited corrected an error in its Q4FY26 XBRL filing, submitting revised consolidated financial results to NSE and BSE on July 23, 2026. The revision aligns the Profit Before Tax figures with the signed PDF report, ensuring accuracy under SEBI Regulation 33(3).